• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

世界各地用于肾脏研究的健康声明数据库。

Health claims databases used for kidney research around the world.

作者信息

van Oosten Manon J M, Logtenberg Susan J J, Edens Mireille A, Hemmelder Marc H, Jager Kitty J, Bilo Henk J G, Stel Vianda S

机构信息

Department of Medical Informatics, Amsterdam UMC, Amsterdam Public Health Research Institute, University of Amsterdam, Amsterdam, The Netherlands.

Department of Internal Medicine, Diakonessenhuis, Utrecht, The Netherlands.

出版信息

Clin Kidney J. 2020 Jun 27;14(1):84-97. doi: 10.1093/ckj/sfaa076. eCollection 2021 Jan.

DOI:10.1093/ckj/sfaa076
PMID:33564408
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7857833/
Abstract

Health claims databases offer opportunities for studies on large populations of patients with kidney disease and health outcomes in a non-experimental setting. Among others, their unique features enable studies on healthcare costs or on longitudinal, epidemiological data with nationwide coverage. However, health claims databases also have several limitations. Because clinical data and information on renal function are often lacking, the identification of patients with kidney disease depends on the actual presence of diagnosis codes only. Investigating the validity of these data is therefore crucial to assess whether outcomes derived from health claims data are truly meaningful. Also, one should take into account the coverage and content of a health claims database, especially when making international comparisons. In this article, an overview is provided of international health claims databases and their main publications in the area of nephrology. The structure and contents of the Dutch health claims database will be described, as well as an initiative to use the outcomes for research and the development of the Dutch Kidney Atlas. Finally, we will discuss to what extent one might be able to identify patients with kidney disease using health claims databases, as well as their strengths and limitations.

摘要

健康索赔数据库为在非实验环境中对大量肾病患者及其健康结局进行研究提供了机会。除此之外,其独特的特性使得对医疗成本或覆盖全国范围的纵向流行病学数据的研究成为可能。然而,健康索赔数据库也存在一些局限性。由于临床数据和肾功能信息常常缺失,肾病患者的识别仅依赖于诊断代码的实际存在。因此,调查这些数据的有效性对于评估从健康索赔数据得出的结果是否真正有意义至关重要。此外,尤其是在进行国际比较时,人们应该考虑健康索赔数据库的覆盖范围和内容。本文概述了国际健康索赔数据库及其在肾脏病领域的主要出版物。将描述荷兰健康索赔数据库的结构和内容,以及利用这些结果进行研究和开发荷兰肾脏图谱的一项举措。最后,我们将讨论利用健康索赔数据库识别肾病患者的能力范围,以及它们的优势和局限性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/606c/7857833/ba412e199a7a/sfaa076f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/606c/7857833/ba412e199a7a/sfaa076f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/606c/7857833/ba412e199a7a/sfaa076f1.jpg

相似文献

1
Health claims databases used for kidney research around the world.世界各地用于肾脏研究的健康声明数据库。
Clin Kidney J. 2020 Jun 27;14(1):84-97. doi: 10.1093/ckj/sfaa076. eCollection 2021 Jan.
2
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
3
Real-World Research on Retinal Diseases Using Health Claims Database: A Narrative Review.利用健康声明数据库对视网膜疾病进行的真实世界研究:一项叙述性综述。
Diagnostics (Basel). 2024 Jul 19;14(14):1568. doi: 10.3390/diagnostics14141568.
4
The validity of Dutch health claims data for identifying patients with chronic kidney disease: a hospital-based study in the Netherlands.荷兰健康声明数据在识别慢性肾脏病患者方面的有效性:荷兰一项基于医院的研究
Clin Kidney J. 2020 Nov 9;14(6):1586-1593. doi: 10.1093/ckj/sfaa167. eCollection 2021 Jun.
5
Agreement Between Administrative Database and Medical Chart Review for the Prediction of Chronic Kidney Disease G category.行政数据库与病历审查在慢性肾脏病G类别预测方面的一致性
Can J Kidney Health Dis. 2020 Oct 10;7:2054358120959908. doi: 10.1177/2054358120959908. eCollection 2020.
6
Estimation of Prevalence of Kidney Disease Treated With Dialysis in China: A Study of Insurance Claims Data.中国透析治疗的肾脏病患病率估计:一项基于保险理赔数据的研究。
Am J Kidney Dis. 2021 Jun;77(6):889-897.e1. doi: 10.1053/j.ajkd.2020.11.021. Epub 2021 Jan 7.
7
Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis.早期转介策略在管理有肾脏疾病标志物的人群中的应用:对临床有效性、成本效益和经济分析证据的系统评价。
Health Technol Assess. 2010 Apr;14(21):1-184. doi: 10.3310/hta14210.
8
Clinical characteristics and disease outcomes in non-diabetic chronic kidney disease: retrospective analysis of a US healthcare claims database.非糖尿病慢性肾脏病的临床特征和疾病转归:美国医疗保健索赔数据库的回顾性分析。
J Nephrol. 2023 Jan;36(1):45-54. doi: 10.1007/s40620-022-01340-x. Epub 2022 May 14.
9
Accuracy of identifying diagnosis of moderate to severe chronic kidney disease in administrative claims data.在行政索赔数据中识别中度至重度慢性肾脏病诊断的准确性。
Pharmacoepidemiol Drug Saf. 2022 Apr;31(4):467-475. doi: 10.1002/pds.5398. Epub 2021 Dec 23.
10
Review of the research databases on population-based Registries of Unified electronic Healthcare system of Kazakhstan (UNEHS): Possibilities and limitations for epidemiological research and Real-World Evidence.哈萨克斯坦统一电子医疗系统(UNEHS)基于人群登记处的研究数据库综述:流行病学研究和真实世界证据的可能性与局限性
Int J Med Inform. 2023 Feb;170:104950. doi: 10.1016/j.ijmedinf.2022.104950. Epub 2022 Dec 7.

引用本文的文献

1
Incidence and risk of cancer emergence among patients post-kidney transplantation in Japan.日本肾移植患者中癌症发生的发病率和风险。
Clin Exp Nephrol. 2025 Aug 27. doi: 10.1007/s10157-025-02748-y.
2
Finding the new potential research on diabetic kidney disease and hemodialysis in healthcare insurance databases: A bibliometric analysis.在医疗保险数据库中寻找糖尿病肾病和血液透析的新潜在研究:一项文献计量分析。
Narra J. 2024 Dec;4(3):e827. doi: 10.52225/narra.v4i3.827. Epub 2024 Oct 9.
3
Prevalence of chronic kidney disease in France: methodological considerations and pitfalls with the use of Health claims databases.

本文引用的文献

1
Linking disease registries and nationwide healthcare administrative databases: the French renal epidemiology and information network (REIN) insight.将疾病登记处与全国性医疗保健管理数据库相链接:法国肾脏流行病学和信息网络(REIN)的见解。
BMC Nephrol. 2020 Jan 28;21(1):25. doi: 10.1186/s12882-020-1692-4.
2
Age-related difference in health care use and costs of patients with chronic kidney disease and matched controls: analysis of Dutch health care claims data.慢性肾病患者与匹配对照组在医疗保健使用及费用方面的年龄差异:荷兰医疗保健索赔数据分析
Nephrol Dial Transplant. 2020 Dec 4;35(12):2138-2146. doi: 10.1093/ndt/gfz146.
3
法国慢性肾脏病的患病率:使用健康声明数据库的方法学考量与陷阱
Clin Kidney J. 2024 Apr 23;17(5):sfae117. doi: 10.1093/ckj/sfae117. eCollection 2024 May.
4
Italian healthcare resource consumption for patients on hemodialysis treated for chronic kidney disease-associated pruritus (CKD-aP).意大利针对慢性肾脏病相关性瘙痒(CKD-aP)接受血液透析治疗患者的医疗资源消耗情况。
Glob Reg Health Technol Assess. 2024 Jan 15;11:22-30. doi: 10.33393/grhta.2024.2696. eCollection 2024 Jan-Dec.
5
Deficiencies in the Recognition and Reporting of Chronic Kidney Disease in Patients With Type 2 Diabetes Mellitus; A Hungarian Nationwide Analysis.2 型糖尿病患者慢性肾脏病识别和报告的不足:一项匈牙利全国性分析。
Int J Public Health. 2023 Aug 29;68:1606151. doi: 10.3389/ijph.2023.1606151. eCollection 2023.
6
Prevalence, Cardiometabolic Comorbidities and Reporting of Chronic Kidney Disease; A Hungarian Cohort Analysis.患病率、心血管代谢合并症与慢性肾脏病报告;匈牙利队列分析。
Int J Public Health. 2023 Mar 30;68:1605635. doi: 10.3389/ijph.2023.1605635. eCollection 2023.
7
Farewell from the Editor-in-Chief: key kidney topics from 2014 to 2021.主编致辞:2014年至2021年肾脏领域的关键话题
Clin Kidney J. 2022 Mar 31;15(4):593-602. doi: 10.1093/ckj/sfac023. eCollection 2022 Apr.
8
Tracing all patients who received insured dialysis treatment in Japan and the present situation of their number of deaths.追踪在日本接受保险透析治疗的所有患者及其死亡人数的现状。
Clin Exp Nephrol. 2022 Apr;26(4):360-367. doi: 10.1007/s10157-021-02163-z. Epub 2022 Jan 1.
9
Differences in Hospitalization Outcomes of Kidney Disease between Patients Who Received Care by Nephrologists and Non-Nephrologist Physicians: A Propensity-Score-Matched Study.肾病患者接受肾病科医生与非肾病科医生治疗后的住院结局差异:一项倾向评分匹配研究
J Clin Med. 2021 Nov 12;10(22):5269. doi: 10.3390/jcm10225269.
10
Premature birth carries a higher risk of nephrotic syndrome: a cohort study.早产增加肾病综合征风险:一项队列研究。
Sci Rep. 2021 Oct 19;11(1):20639. doi: 10.1038/s41598-021-00164-2.
Healthcare costs of patients on different renal replacement modalities - Analysis of Dutch health insurance claims data.
不同肾脏替代治疗方式患者的医疗费用 - 荷兰健康保险索赔数据分析。
PLoS One. 2019 Aug 15;14(8):e0220800. doi: 10.1371/journal.pone.0220800. eCollection 2019.
4
Contemporary Trends in Clinical Outcomes among Dialysis Patients with Medicare Coverage.透析患者的医疗保险覆盖范围下临床结果的当代趋势。
Am J Nephrol. 2019;50(1):63-71. doi: 10.1159/000500943. Epub 2019 Jun 14.
5
National Health Insurance Databases in Indonesia, Vietnam and the Philippines.印度尼西亚、越南和菲律宾的国家健康保险数据库。
Pharmacoecon Open. 2019 Dec;3(4):517-526. doi: 10.1007/s41669-019-0127-2.
6
Secular Trends in the Cost of Immunosuppressants after Solid Organ Transplantation in the United States.美国实体器官移植后免疫抑制剂成本的长期趋势。
Clin J Am Soc Nephrol. 2019 Mar 7;14(3):421-430. doi: 10.2215/CJN.10590918. Epub 2019 Feb 28.
7
Trends in the Medical Complexity and Outcomes of Medicare-insured Patients Undergoing Kidney Transplant in the Years 1998-2014.1998-2014 年医疗保险覆盖的肾移植患者的医疗复杂性和结局趋势。
Transplantation. 2019 Nov;103(11):2413-2422. doi: 10.1097/TP.0000000000002670.
8
Executive summary for the 2015 Annual Data Report of the China Kidney Disease Network (CK-NET).2015 年中国肾脏病网络(CK-NET)年度数据报告执行摘要。
Kidney Int. 2019 Mar;95(3):501-505. doi: 10.1016/j.kint.2018.11.011.
9
Global overview of health systems oversight and financing for kidney care.肾脏护理的卫生系统监督与融资全球概述。
Kidney Int Suppl (2011). 2018 Feb;8(2):41-51. doi: 10.1016/j.kisu.2017.10.008. Epub 2018 Jan 19.
10
Estimating disease prevalence from drug utilization data using the Random Forest algorithm.使用随机森林算法从药物利用数据估算疾病流行率。
Eur J Public Health. 2019 Aug 1;29(4):615-621. doi: 10.1093/eurpub/cky270.